Advanced Services at Palm Harbor
Diagnostics
Digital X-Ray Digitization (DXD)
Precise quantification of ligament laxity damage, adhering to AMA guidelines.
Quantitative EEG (QEEG)
Advanced brain activity monitoring using the Zeto EEG system for rapid, precise analysis.
ProBalance 360
Comprehensive balance assessment for early detection and personalized treatment plans.
EyeBox by Oculogica
FDA-cleared concussion diagnosis tool providing objective insights without baseline tests.
Treatments
Hyperbaric Oxygen Therapy
Advanced therapy to enhance oxygen delivery, promote healing, and optimize brain function.
Vestibular Therapy
Data-driven rehabilitation using ProBalance 360 for vestibular disorders and balance deficits.
NeuroStar TMS Therapy
FDA-cleared treatment for Major Depressive Disorder and OCD using advanced magnetic stimulation.
Concussion Therapy
Innovative EyeSync treatment for concussions and mild Traumatic Brain Injury (mTBI) recovery.
Vibration Therapy
PowerPlate technology for improving strength, flexibility, and overall physical well-being.
Revolutionizing Neurological Care
At Peak BrainLab Palm Harbor, we combine cutting-edge technology with data-driven approaches to deliver unparalleled neurological diagnostics and treatments. Our state-of-the-art facility offers innovative solutions for patients, healthcare providers, legal professionals, and investors.
How do we ensure accurate diagnostics?
Our facility utilizes advanced technologies like Digital X-Ray Digitization (DXD), Quantitative EEG (QEEG), and FDA-cleared diagnostic tools such as EyeBox. These provide objective, quantifiable data for precise neurological assessments.
What benefits do we offer to healthcare providers and insurers?
We provide comprehensive, evidence-based reports adhering to AMA guidelines. Our data-driven approach ensures cost-effective treatments and improved patient outcomes, benefiting both healthcare providers and insurance companies.
How do we support legal professionals and investors?
For attorneys, we provide objective, court-admissible neurological assessments. For investors, our scalable model combines clinical excellence with technological innovation, positioning us for growth in the expanding field of advanced neurological care.